Iterum Therapeutics PLC
NASDAQ:ITRM
Iterum Therapeutics PLC
Cash from Investing Activities
Iterum Therapeutics PLC
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
Cash from Investing Activities
$23.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Perrigo Company PLC
NYSE:PRGO
|
Cash from Investing Activities
-$77.5m
|
CAGR 3-Years
26%
|
CAGR 5-Years
9%
|
CAGR 10-Years
28%
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Cash from Investing Activities
-$163.1m
|
CAGR 3-Years
46%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-26%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Cash from Investing Activities
-$50.1m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Cash from Investing Activities
-$54.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Cash from Investing Activities
€40.3m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Iterum Therapeutics PLC's Cash from Investing Activities?
Cash from Investing Activities
23.3m
USD
Based on the financial report for Dec 31, 2023, Iterum Therapeutics PLC's Cash from Investing Activities amounts to 23.3m USD.
What is Iterum Therapeutics PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 1Y
67%
Over the last year, the Cash from Investing Activities growth was 67%.